# Nanoligent S.L.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanoligent-s-l

- Industry: Biotechnology
- Headquarters: Barcelona, Spain
- Website: www.nanoligent.com
- Total disclosed funding: $18M
- Latest round: Series A (Sep 6, 2025)
- Investors on record: 7

## About

Based in Spain, and founded in 2017, Nanoligent S.L. operates as a biotechnology company. The company was founded by its Scientific Advisor Dr. A. Villaverde, and Scientific Advisor Dra. E. Vázquez from the Nanobiotecnology Group of the UAB; Scientific Advisor Dr. R. Mangues from the Research Institut of Hospital de Sant Pau, and Chairman Dr. M. Rodríguez. It was formed as a spinoff of the Universitat Autònoma de Barcelona (UAB) and Institut de Recerca de l’Hospital de la Santa Creu I Sant Pau. In October 2025, Nanoligent S.L. raised EUR 12 million in venture funding led by Inveready Asset Management, with participation from Center for Technological & Industrial Development, Clave Capital, i&i Bio, Italian Angels for Growth and AVANTECA Partners. As of 2022, the company is led by its CEO Montserrat Cano Biosca.

Nanoligent uses engineering and nanobiotechnology to create and develop nanotechnology-based medications and targeted drug therapy for the treatment of more than 20 different metastatic cancer types. As of 2022, the company's portfolio includes NNL-121, a self-assembling protein nanoparticle that targets Cancer cell receptor CXCR4 and can be utilized to treat metastatic colorectal cancer.

The company will use the October 2025 funding to complete regulatory preclinical development of its lead compound NNL1524 and initiate a Phase Ia clinical trial in patients with solid tumors.

## Funding rounds

- Series A, Sep 6, 2025, $14M — Inveready Asset Management, Clave Capital, Italian Angels for Growth, AVANTECA Partners, i&i Bio, Center for Technological & Industrial Development
- Seed, Sep 27, 2022, $2.7M — Italian Angels for Growth, AVANTECA Partners, i&i Bio
- Seed, Feb 3, 2022, $1.1M — IAG Capital Partners, AVANTECA Partners

## Investors

- IAG Capital Partners (https://capitalatlas.ai/funds/iag-capital-partners) — Seed
- AVANTECA Partners — Seed, Series A
- Italian Angels for Growth (https://capitalatlas.ai/funds/italian-angels-for-growth) — Seed, Series A
- i&i Bio (https://capitalatlas.ai/funds/i-i-bio) — Seed, Series A
- Inveready Asset Management (https://capitalatlas.ai/funds/inveready-asset-management) — Series A
- Clave Capital — Series A
- Center for Technological & Industrial Development (https://capitalatlas.ai/funds/center-for-technological-industrial-development) — Series A